Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002020 stock hub

SHE/002020 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002020is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.2B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002020

In the news

Latest news · SHE/002020

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.3

P25 17.1P50 24.2P75 37.8

Trailing P/E17.5

P25 23.5P50 41.3P75 83.2

ROE12.5

P25 -0.9P50 4.1P75 8.8

ROIC11.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002020 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

CNY

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,869
Employees Change	-40%
Employees Change Percent	-1.02
Enterprise value	CNY 11.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000001K73
Last refreshed	2026-05-10
Market cap	CNY 12.2B
Price	CNY 15.05
Price currency	CNY
Rev Per Employee	1,033,341.65x
Sector	Healthcare
Sic	2833
Symbol	she/002020
Website	https://www.jingxinpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.82%
EV Earnings	15.92x
EV/EBIT	16.34x
EV/EBITDA	10.96x
EV/FCF	22.62x
EV/Sales	2.84x
FCF yield	4.1%
Forward P/E	14.33x
P/B ratio	2.15x
P/E ratio	17.55x
P/S ratio	3.06x
PE Ratio10 Y	21.02x
PE Ratio3 Y	16.43x
PE Ratio5 Y	14.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.37%
EBITDA Margin	25.54%
FCF margin	12.55%
Gross margin	48.71%
Gross Profit	CNY 1.9B
Gross Profit Growth	-9.81%
Gross Profit Growth Q	11.96%
Gross Profit Growth3 Y	-1.12%
Gross Profit Growth5 Y	-1.52%
Net Income	CNY 712.6M
Net Income Growth	-1.21%
Net Income Growth Q	20.63%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	3.36%
Net Income Growth5 Y	12.02%
Pretax Margin	20.82%
Profit Margin	17.82%
Profit Per Employee	CNY 184,172
Profitable Years	17
ROA	5.24
Roa5y	5.46
ROCE	11.5
ROE	12.47
Roe5y	13.69
ROIC	11.4
Roic5y	17.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.95%
Cagr15y	11.13%
Cagr1y	14.19%
Cagr20y	15.47%
Cagr3y	1.95%
Cagr5y	14.4%
Div CAGR10	18.8%
Div CAGR3	5.27%
Div CAGR5	3.71%
EPS Growth	2.11
EPS Growth Q	25.08
EPS Growth Years	2
EPS Growth3 Y	4.61
EPS Growth5 Y	11.99
FCF Growth	-22.45%
FCF Growth Q	110.07%
FCF Growth3 Y	37.75%
FCF Growth5 Y	18.69%
OCF Growth	-19.46%
OCF Growth Q	60.27%
OCF Growth10 Y	15.8%
OCF Growth3 Y	-7.25%
OCF Growth5 Y	4.03%
Revenue Growth	-6.63x
Revenue Growth Q	-2.82x
Revenue Growth Years	0x
Revenue Growth3 Y	2.57x
Revenue Growth5 Y	3.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.48
Assets	CNY 8B
Cash	CNY 662.8M
Current Assets	CNY 3.2B
Current Liabilities	CNY 1.6B
Debt	CNY 245.7M
Debt EBITDA	CNY 0.24
Debt Equity	CNY 0.04
Debt FCF	CNY 0.49
Equity	CNY 5.7B
Interest Coverage	125.7
Liabilities	CNY 2.3B
Long Term Assets	CNY 4.8B
Long Term Liabilities	CNY 721.1M
Net Cash	CNY 417.1M
Net Cash By Market Cap	CNY 3.41
Net Cash Growth	13.82%
Net Debt EBITDA	CNY -0.41
Net Debt Equity	CNY -0.07
Net Debt FCF	CNY -0.83
Tangible Book Value	CNY 4.9B
Tangible Book Value Per Share	CNY 6.04
WACC	3.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.62
Inventory Turnover	2.66
Net Working Capital	CNY 762M
Quick ratio	0.83
Working Capital	CNY 1.2B
Working Capital Turnover	CNY 3.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.25%
Dividend Growth	16.67%
Dividend Growth Years	1%
Dividend per share	CNY 0.35
Dividend Years	14
Dividend Yield	2.33%
Ex Div Date	2025-05-29
Last Dividend	CNY 0.35
Payout Frequency	Annual
Payout Ratio	39.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	78.16%
1Y total return	14.18%
200-day SMA	17.92
3Y total return	5.95%
50-day SMA	15.66
50-day SMA vs 200-day SMA	50under200
5Y total return	95.95%
All Time High	22.62
All Time High Change	-33.47%
All Time High Date	2025-09-25
All Time Low	0.77
All Time Low Change	1,847.21%
All Time Low Date	2008-10-13
ATR	0.44
Beta	-0.06
Beta1y	-0.16
Beta2y	0.18
Ch YTD	-20.71
High	15.17
High52	22.62
High52 Date	2025-09-25
High52ch	-33.47%
Low	14.81
Low52	12.79
Low52 Date	2025-06-30
Low52ch	17.67%
Ma50ch	-3.86%
Price vs 200-day SMA	-16.02%
RSI	43.54
RSI Monthly	50.21
RSI Weekly	38.8
Sharpe ratio	0.36x
Sortino ratio	0.75
Total Return	5.58%
Tr YTD	-20.71
Tr15y	386.74%
Tr1m	-6.52%
Tr1w	1.14%
Tr3m	-11.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 694.4M
Operating Income Growth	-6.43
Operating Income Growth Q	6.97
Operating Income Growth3 Y	4.13
Operating Income Growth5 Y	11.89
Operating margin	17.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	464,801,628%
Net Borrowing	-205,659,784
Shares Insiders	26.3%
Shares Institutions	8.76%
Shares Out	813,757,845
Shares Qo Q	5.83%
Shares Yo Y	-3.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 501.6M
Average Volume	11,314,567.65x
Bv Per Share	6.94
CAPEX	CNY -227.4M
Ch10y	41.75
Ch15y	275.1
Ch1m	-6.52
Ch1w	1.14
Ch1y	11.15
Ch20y	1,268.2
Ch3m	-11.31
Ch3y	-1.44
Ch5y	70.54
Ch6m	-16.48
Change	0.2%
Change From Open	0.13
Close	15.02
Days Gap	0.07
Depreciation Amortization	326,776,619
Dollar Volume	190,653,701
Earnings Date	2026-04-24
EBIT	CNY 694.4M
EBITDA	CNY 1B
EPS	CNY 0.86
F Score	5
FCF	CNY 501.6M
FCF EV Yield	4.42x
FCF Per Share	CNY 0.62
Financing CF	-1,105,661,687
Fiscal Year End	December
Founded	1,990
Goodwill	335,604,538
Graham Number	11.57638
Graham Upside	-23.08
Income Tax	CNY 112.4M
Investing CF	604,848,965
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2021-05-28
Last Split Type	Forward
Lynch Fair Value	CNY 10.31
Lynch Upside	-31.51
Ma150	17.84
Ma150ch	-15.64%
Ma20	15.4
Ma20ch	-2.25%
Net CF	229,442,670
Next Earnings Date	2026-08-26
Open	15.03
P FCF Ratio	24.42
P OCF Ratio	16.8
Payment Date	2025-05-29
Position In Range	66.67
Ppne	2,207,282,729
Price Date	2026-05-08
Price EBITDA	CNY 11.99
Ptbv Ratio	2.49
Relative Volume	1.12x
Revenue	3,997,998,854x
Tax By Revenue	2.81x
Tax Rate	13.51%
Tr20y	1,675.51%
Tr6m	-16.48%
Volume	12,668,020
Z Score	4.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002020 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$0.35 annual per share

Payout ratio

+40.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.7%

1 consecutive years of growth

Total shareholder yield

+5.6%

Next ex-dividend date: 2025-05-29

Performance

SHE/002020 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002020?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.8%

Share of float held by funds and institutions

Insider ownership

+26.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.3%

Negative means the company is buying back shares.

Technical

SHE/002020 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.5

Neutral momentum band

Price vs 200-day MA

-16.0%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002020

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002020 stock rating?

she/002020 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002020 analysis?

The full report lives at /stocks/she/002020/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002020?

The latest report frames she/002020 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002020 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.